Advertisement
ResearchIn-Press PreviewOncology Open Access | 10.1172/JCI170953
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Sinha, S. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Callow, B. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Farfel, A. in: JCI | PubMed | Google Scholar |
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Roy, S. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Chen, S. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Masotti, M. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Rajendran, S. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Buschhaus, J. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Espinoza, C. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Luker, K. in: JCI | PubMed | Google Scholar |
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Ghosh, P. in: JCI | PubMed | Google Scholar
1Department of Cellular and Molecular Medicine, School of Medicine, UCSD, La Jolla, United States of America
2Center for Molecular Imaging, Department of Radiology, University of Michigan, Ann Arbor, United States of America
3Biostatistics, School of Public Health, University of Michigan, Ann Arbor, United States of America
Find articles by Luker, G. in: JCI | PubMed | Google Scholar |
Published October 31, 2024 - More info
Estrogen receptor-positive (ER+) breast cancer commonly disseminates to bone marrow, where interactions with mesenchymal stromal cells (MSCs) shape disease trajectory. We modeled these interactions with tumor-MSC co-cultures and used an integrated transcriptome-proteome-network-analyses workflow to identify a comprehensive catalog of contact-induced changes. Conditioned media from MSCs failed to recapitulate genes and proteins, some borrowed and others tumor-intrinsic, induced in cancer cells by direct contact. Protein-protein interaction networks revealed the rich connectome between ‘borrowed’ and ‘intrinsic’ components. Bioinformatics prioritized one of the ‘borrowed’ components, CCDC88A/GIV, a multi-modular metastasis-related protein that has recently been implicated in driving a hallmark of cancer, growth signaling autonomy. MSCs transferred GIV protein to ER+ breast cancer cells (that lack GIV) through tunnelling nanotubes via connexin (Cx)43-facilitated intercellular transport. Reinstating GIV alone in GIV-negative breast cancer cells reproduced approximately 20% of both the ‘borrowed’ and the ‘intrinsic’ gene induction patterns from contact co-cultures; conferred resistance to anti-estrogen drugs; and enhanced tumor dissemination. Findings provide a multiomic insight into MSC→tumor cell intercellular transport and validate how transport of one such candidate, GIV, from the haves (MSCs) to have-nots (ER+ breast cancer) orchestrates aggressive disease states.